Robert Faturechi

Executives Cut Their Own Salaries to Save Even More on Taxes Under Trump Law

Some business owners used a loophole in the Trump tax cut to reclassify their wages as profit, reducing their tax bill.

by: Robert Faturechi &; Justin Elliott,; ProPublica

August 19, 2021

Trump’s Tax Cut Helped 82 Ultrawealthy Households Save More Than $1 Billion

The millions spent on campaign donations and lobbying for the cuts are minuscule compared with the savings of the rich.

by: Justin Elliott &; Robert Faturechi,; ProPublica

August 15, 2021

Stadium Workers Are Paying Higher Tax Rates Than Sports Team Owners

Billionaire owners are paying lower tax rates than their millionaire players or low-wage concession workers.

by: Robert Faturechi,; Justin Elliott &; Ellis Simani,; ProPublica

July 10, 2021

Leading Manhattan DA Candidate Has Repeatedly Paid Almost No Federal Income Tax

Tali Farhadian Weinstein and her husband paid nothing (or almost nothing) to the IRS four times in six years.

by: Robert Faturechi &; Jeff Ernsthausen,; ProPublica

June 19, 2021

Senator Perdue’s Ethics Concerns Include Sale of His Home to a Senate Lobbyist

The same year an org lobbied the Senate, one of its board governors paid Perdue $1.8 million for his home in D.C.

by: Robert Faturechi,; ProPublica

December 10, 2020

Georgia Senator Privately Pushed for Lucrative Tax Break for Sports Teamowners

The failed effort could have helped several of his donors, including fellow Sen. Kelly Loeffler.

by: Robert Faturechi &; Justin Elliott,; ProPublica

November 20, 2020

This Treasury Official Is Running the Bailout. It’s Been Great for His Family.

Justin Muzinich’s ongoing ties to the family firm present a thicket of potential conflicts of interest.

by: Justin Elliott,; Lydia DePillis &; Robert Faturechi,; ProPublica

June 2, 2020

News Analysis

Tom Price’s $150,000-Plus Stock Windfall

The HHS secretary divested his shares in a small biotech company — and in the process doubled his money.

by: Robert Faturechi,; ProPublica

April 8, 2017

Environment & Health

When a Study Cast Doubt on a Heart Pill, the Drug Company Turned to Tom Price

Price’s actions have come under scrutiny in the past.

by: Robert Faturechi,; ProPublica

January 23, 2017